Evidence map›Paper›PMID 35250586›Full record

ArticleFrontiers in pharmacology2022

Hengli

Limin Liao, Qinggang Liu, Huiling Cong, Zhihui Xu, Enhui Li, Zhiliang Weng, Haihong Jiang, Ben Liu, Xiao Huang, Shujie Xia and 26 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 18 institutions in 1 country.

Limin LiaoDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
Qinggang LiuDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
Huiling CongDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
Zhihui XuDepartment of Urology, Zhejiang Provincial People's Hospital, Hangzhou, China.
Enhui LiDepartment of Urology, Zhejiang Provincial People's Hospital, Hangzhou, China.
Zhiliang WengDepartment of Urology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Haihong JiangDepartment of Urology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Ben LiuDepartment of Urology, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Xiao HuangDepartment of Urology, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Shujie XiaDepartment of Urology, Shanghai First People's Hospital, Shanghai, China.
Wei WenDepartment of Urology, Shanghai First People's Hospital, Shanghai, China.
Juan WuDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
Guowei ShiDepartment of Urology, Shanghai Fifth People's Hospital, Shanghai, China.
Yang WangDepartment of Urology, Shanghai Fifth People's Hospital, Shanghai, China.
Peijun LiDepartment of Urology, Ningxia Medical University General Hospital, Xining, China.
Yang YuDepartment of Urology, Ningxia Medical University General Hospital, Xining, China.
Zujun FangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Jie ZhengDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Ye TianDepartment of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Donghao ShangDepartment of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Hanzhong LiDepartment of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Zhongming HuangDepartment of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Liqun ZhouDepartment of Urology, Peking University First Hospital, Beijing, China.
Yunxiang XiaoDepartment of Urology, Peking University First Hospital, Beijing, China.
Yaoguang ZhangDepartment of Urology, Beijing Hospital, Beijing, China.
Jianlong WangDepartment of Urology, Beijing Hospital, Beijing, China.
Xiaodong ZhangDepartment of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Peng ZhangDepartment of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Dongwen WangDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Xuhui ZhangDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Keji XieDepartment of Urology, Guangzhou First People's Hospital, Guangzhou, China.
Bin WangDepartment of Urology, Guangzhou First People's Hospital, Guangzhou, China.
Lulin MaDepartment of Urology, Peking University Third Hospital, Beijing, China.
Xiaojun TianDepartment of Urology, Peking University Third Hospital, Beijing, China.
Lijun ChenDepartment of Urology, Fifth Medical Center of PLA General Hospital, Beijing, China.
Jinkai DongDepartment of Urology, Fifth Medical Center of PLA General Hospital, Beijing, China.
Capital Medical University · CNShanxi Medical University · CNBeijing Hospital · CNChina Rehabilitation Research Center · CNChinese PLA General Hospital · CNFirst Affiliated Hospital of Wenzhou Medical University · CNFirst Affiliated Hospital Zhejiang University · CNGuangzhou First People's Hospital · CNNingxia Medical University General Hospital · CNPeking Union Medical College Hospital · CNPeking University Third Hospital · CNShanghai First People's Hospital · CNZhejiang Provincial People's Hospital · CNFudan University · CNHuashan Hospital · CNPeking University · CNPeking University First Hospital · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

botulinum toxin type AChinaHengli®overactive bladderrandomized controlled trial

Identifiers

PMID35250586
PMCPMC8894806
OpenAlexW4212845674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.